BACKGROUND: The relationship between advanced glycation end products and arterial stiffness has previously been examined in highly selected groups of patients with diabetes or hypertension. Our aim was to determine whether elevated serum advanced glycation end products are associated with increased arterial stiffness in relatively healthy, community-dwelling adults. METHODS: Aortic pulse wave velocity (PWV), an index of aortic stiffness, and serum advanced glycation end products (AGEs), as represented by the specific AGE, serum carboxymethyl-lysine (CML), were measured in 493 adults, aged 26-93 years, who participated in the Baltimore Longitudinal Study of Aging (BLSA). RESULTS: Mean (s.d.) PWV (m/s) was 6.6 (1.8) m/s. Mean CML was 0.47 (0.13) microg/ml. Serum CML (per 1 s.d.) was associated with PWV (beta = 0.16, s.e. = 0.07, P = 0.02), adjusting for age, sex, body mass index, mean arterial pressure, fasting plasma glucose, high-density lipoprotein cholesterol, smoking, and other covariates. After excluding all diabetic patients, serum CML (per 1 s.d.) was associated with PWV (beta = 0.18, s.e. = 0.07, P = 0.009), adjusting for the same covariates. CONCLUSIONS: Elevated AGEs are associated with increased arterial stiffness, a known predictor of adverse cardiovascular outcomes, among relatively healthy community-dwelling adults. Interventions to lower levels of AGEs, such as altering the pattern of dietary intake, warrant examination as putative novel strategies to lower arterial stiffness in adults.
BACKGROUND: The relationship between advanced glycation end products and arterial stiffness has previously been examined in highly selected groups of patients with diabetes or hypertension. Our aim was to determine whether elevated serum advanced glycation end products are associated with increased arterial stiffness in relatively healthy, community-dwelling adults. METHODS: Aortic pulse wave velocity (PWV), an index of aortic stiffness, and serum advanced glycation end products (AGEs), as represented by the specific AGE, serum carboxymethyl-lysine (CML), were measured in 493 adults, aged 26-93 years, who participated in the Baltimore Longitudinal Study of Aging (BLSA). RESULTS: Mean (s.d.) PWV (m/s) was 6.6 (1.8) m/s. Mean CML was 0.47 (0.13) microg/ml. Serum CML (per 1 s.d.) was associated with PWV (beta = 0.16, s.e. = 0.07, P = 0.02), adjusting for age, sex, body mass index, mean arterial pressure, fasting plasma glucose, high-density lipoprotein cholesterol, smoking, and other covariates. After excluding all diabeticpatients, serum CML (per 1 s.d.) was associated with PWV (beta = 0.18, s.e. = 0.07, P = 0.009), adjusting for the same covariates. CONCLUSIONS: Elevated AGEs are associated with increased arterial stiffness, a known predictor of adverse cardiovascular outcomes, among relatively healthy community-dwelling adults. Interventions to lower levels of AGEs, such as altering the pattern of dietary intake, warrant examination as putative novel strategies to lower arterial stiffness in adults.
Authors: Kim Sutton-Tyrrell; Samer S Najjar; Robert M Boudreau; Lakshmi Venkitachalam; Varant Kupelian; Eleanor M Simonsick; Richard Havlik; Edward G Lakatta; Harold Spurgeon; Stephen Kritchevsky; Marco Pahor; Douglas Bauer; Anne Newman Journal: Circulation Date: 2005-06-20 Impact factor: 29.690
Authors: Stephane Laurent; John Cockcroft; Luc Van Bortel; Pierre Boutouyrie; Cristina Giannattasio; Daniel Hayoz; Bruno Pannier; Charalambos Vlachopoulos; Ian Wilkinson; Harry Struijker-Boudier Journal: Eur Heart J Date: 2006-09-25 Impact factor: 29.983
Authors: Francesco U S Mattace-Raso; Tischa J M van der Cammen; Albert Hofman; Nicole M van Popele; Michiel L Bos; Maarten A D H Schalekamp; Roland Asmar; Robert S Reneman; Arnold P G Hoeks; Monique M B Breteler; Jacqueline C M Witteman Journal: Circulation Date: 2006-02-07 Impact factor: 29.690
Authors: William C Little; Michael R Zile; Dalane W Kitzman; W Gregory Hundley; Terrence X O'Brien; Robert C Degroof Journal: J Card Fail Date: 2005-04 Impact factor: 5.712
Authors: Zoltan Ungvari; Gabor Kaley; Rafael de Cabo; William E Sonntag; Anna Csiszar Journal: J Gerontol A Biol Sci Med Sci Date: 2010-06-24 Impact factor: 6.053
Authors: Richard D Semba; Sarah K Gebauer; David J Baer; Kai Sun; Randi Turner; Harry A Silber; Sameera Talegawkar; Luigi Ferrucci; Janet A Novotny Journal: J Nutr Date: 2014-04-17 Impact factor: 4.798
Authors: Eric J Brunner; Martin J Shipley; Daniel R Witte; Archana Singh-Manoux; Annie R Britton; Adam G Tabak; Carmel M McEniery; Ian B Wilkinson; Mika Kivimaki Journal: Hypertension Date: 2011-03-28 Impact factor: 10.190
Authors: Majd AlGhatrif; James B Strait; Chris H Morrell; Marco Canepa; Jeanette Wright; Palchamy Elango; Angelo Scuteri; Samer S Najjar; Luigi Ferrucci; Edward G Lakatta Journal: Hypertension Date: 2013-09-03 Impact factor: 10.190
Authors: Richard D Semba; Kai Sun; Ann V Schwartz; Ravi Varadhan; Tamara B Harris; Suzanne Satterfield; Melissa Garcia; Luigi Ferrucci; Anne B Newman Journal: J Hypertens Date: 2015-04 Impact factor: 4.844
Authors: Natasha J McIntyre; Lindsay J Chesterton; Stephen G John; Helen J Jefferies; James O Burton; Maarten W Taal; Richard J Fluck; Christopher W McIntyre Journal: Clin J Am Soc Nephrol Date: 2009-11-05 Impact factor: 8.237